Open original FDA record ↗Recall record
- FDA identifier
- Z-0020-2025
- Company in FDA record
- Philips North America Llc
- FDA classification date
- Oct 4, 2024
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Devices with Option CP2 and initially programmed to software version P.01.01 were configured incorrectly at the factory. Therefore, Enhanced ECG Capabilities provided by Option CP2 were not enabled in these devices. Without Option C01 Full Arrhythmia, the device will not provide the yellow alarms for enhanced arrhythmia detection. This is a retrospectively reported recall from 6/14/23.
Source facts
- Action
- PHILIPS issued Urgent Field Safety Notice (2023-CC-HPM-019) on 6/14/23. Letter states reason for recall, health risk and action to take: " Please be aware that without Option C01 (Full Arrhythmia) the device will not provide the yellow alarms for enhanced arrhythmia detection. " Review the contents of this letter with your staff. " Pass this notice to all those who need to be aware within your organization or to any organization where the affected devices might have been transferred. 5. Actions taken by Philips to correct the problem Philips Representative will contact you to arrange reload of current device's software to enable missing software options (C0l, C13, C51, C54). If you need any further information, please contact your local Philips representative
- Initiated
- 2023-06-14
- Root cause
- Process control
- Distribution
- Foreign Only: Denmark France Germany Japan United Kingdom
- Recall number
- Z-0020-2025
- Recall status
- Open, Classified
- CDRH record ID
- 209981
- FDA classified
- 2024-10-04
- Recall event number
- 95324